The miR-103 expression could be related to impaired insulin sensitivity and glucose uptake, possibly an attractive pharmacological target in obesity and diabetes, promoting cell adipogenesis by targeting MEF2D and activating AKT/mTOR signaling pathway (81). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.